Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32908bbdcc7952c00c0a461bd9d6f546 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
filingDate |
2007-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e9efb31fcfddf3f090b7c88bb6588c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_176a1cc436e2e931ae8b80a50e7a3858 |
publicationDate |
2014-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2470333-T3 |
titleOfInvention |
Compositions and methods to increase blood platelet levels in humans |
abstract |
An oral immediate release dosage formulation comprising a pharmaceutically acceptable excipient and 10 to 75 mg of the drug of Formula I or a pharmaceutically acceptable salt thereof, the dosage form providing a maximum mean plasma concentration (Cmax) of 3 ng / ml at 8 ng / ml per 1 mg of the drug included in the dosage form after administration of a single dose to a human individual: ** Formula ** |
priorityDate |
2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |